We’ve reached half a million deaths from the coronavirus in the US. But most of these deaths and the grueling medical ordeals leading up to them have remained largely hidden from view. The majority of terminally ill Covid-19 patients typically spend their last days or weeks isolated in ICUs to keep the virus from spreading.
“Most of what I’m seeing is behind closed curtains, and the general public isn’t seeing this side of it,” says Todd Rice, a critical care and pulmonology specialist at Vanderbilt University Medical Center. Even “families are only seeing a little bit of it,” he says. As a result, most of us have been “protected and sheltered from seeing the worst of this disease.”
美国高校防疫任务艰巨 - 宝鸡市母婴用品有限公司 onmasr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onmasr.com Daily Mail and Mail on Sunday newspapers.
Study: Individuals recovering from COVID-19 helpful for Sustained cellular immune dysregulation ANI | Updated: Jan 03, 2021 22:10 IST
Birmingham [UK], January 3 (ANI): A recent study has determined that Covid-19 patients might be helpful for clinicians to better understand how the unknown SARS-CoV-2 virus acts.
According to a study published in the Journal of Clinical Investigation, many infected patients remain asymptomatic or have mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease with atypical pneumonia and multiple system organ failures.
Since the first cases were reported in December 2019, the SARS-CoV-2 virus that causes COVID-19 has surged into a pandemic, with cases and deaths still mounting. Ongoing observational clinical research has become a priority to better understand how this previously unknown virus acts, and findings from this research can better inform treatment and vaccine desig
Study finds sustained cellular immune dysregulation in patients recovering from COVID-19 ANI | Updated: Jan 02, 2021 23:14 IST
Birmingham [UK], January 2 (ANI): Findings from recent researches on COVID-19 and observational clinical research of COVID-19 patients can help clinicians explore more about the virus to better inform treatment and vaccine design.
The University of Alabama at Birmingham researchers, led by first-author Jacob Jake Files and co-senior authors Nathan Erdmann, M.D., PhD, and Paul Goepfert, M.D., have now reported their observational study, Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection, published in the Journal of Clinical Investigation.
COVID-19, which has killed 1.7 million people worldwide, does not follow a uniform path. Many infected patients remain asymptomatic or have mild symptoms. Others, especially those with comorbidities, can develop severe clinical disease wit